Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion type Assertion NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_head.
- NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion description "[In 2005, a clinical trial using HF10 to treat pancreatic cancer was initiated. screened In this Japanese study, 17 patients received HF10 in their tumor sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_provenance.
- NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion evidence source_evidence_literature NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_provenance.
- NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion SIO_000772 26176043 NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_provenance.
- NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion wasDerivedFrom befree-2016 NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_provenance.
- NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_assertion wasGeneratedBy ECO_0000203 NP1290154.RAfaAoDiYuve25c3p-PiR8W4peywIuUGciSjwA2AnP_CU130_provenance.